Active ingredients: epirubicin
What it is used for
Epirubicin hydrochloride has produced responses in a wide spectrum of neoplastic disease. DBL Epirubicin Hydrochloride Injection and DBL Epirubicin Hydrochloride for Injection are indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small cell lung cancer, lymphoma (non-Hodgkin's lymphoma), advanced/metastatic soft tissue sarcoma and superficial bladder cancer (Tis; Ta). In bladder cancer, DBL Epirubicin Hydrochloride Injection and DBL Epirubicin Hydrochloride for Injection are also indicated in the prophylaxis of recurrence after transurethral resection of T1 papillary cancers and stage Ta multifocal papillary cancers (Grade 2 and 3).
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Intravenous
Always read the label. If symptoms persist see your healthcare professional.
A clear, red solution free from visible particulates
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient epirubicin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)